Immunome, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 5.50 M | $58.41 M | -4.55% | 9.14% |
| REDMILE GROUP, LLC | 02/14/2025 | 4.83 M | $51.27 M | -1.26% | 8.02% |
| BLACKROCK, INC. | 02/07/2025 | 4.12 M | $43.81 M | 3.60% | 6.85% |
| FMR LLC | 02/13/2025 | 3.92 M | $41.62 M | -7.23% | 6.51% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 3.88 M | $41.20 M | 0.00% | 6.44% |
| 02/14/2025 | 3.48 M | $36.94 M | 100.00% | 5.78% | |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 3.46 M | $36.73 M | -0.92% | 5.74% |
| VANGUARD GROUP INC | 02/11/2025 | 3.00 M | $31.90 M | -4.09% | 4.99% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 2.28 M | $24.24 M | 12.10% | 3.79% |
| STATE STREET CORP | 02/14/2025 | 2.13 M | $22.59 M | -2.77% | 3.53% |
| OPALEYE MANAGEMENT INC. | 02/14/2025 | 2.04 M | $21.66 M | 64.85% | 3.39% |
| JEFFERIES FINANCIAL GROUP INC. | 02/27/2025 | 2.00 M | $21.24 M | 6.62% | 3.32% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.23 M | $13.05 M | 1.77% | 2.04% |
| MARSHALL WACE, LLP | 02/13/2025 | 1.22 M | $12.92 M | -17.12% | 2.02% |
| WOODLINE PARTNERS LP | 02/14/2025 | 980,925 | $10.42 M | 6.12% | 1.63% |
| SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 746,824 | $7.93 M | 10.35% | 1.24% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 688,790 | $7.31 M | 46.35% | 1.14% |
| JPMORGAN CHASE & CO | 02/12/2025 | 648,610 | $6.89 M | 2,540.38% | 1.08% |
| NORTHERN TRUST CORP | 02/14/2025 | 516,491 | $5.49 M | 9.12% | 0.86% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 500,000 | $5.31 M | 127.27% | 0.83% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 457,252 | $4.86 M | 3.34% | 0.76% |
| TD ASSET MANAGEMENT INC | 02/11/2025 | 423,302 | $4.50 M | 7.27% | 0.70% |
| MORGAN STANLEY | 02/14/2025 | 398,867 | $4.24 M | 37.98% | 0.66% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 316,000 | $3.36 M | 2,696.46% | 0.52% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 314,239 | $3.34 M | 100.00% | 0.52% |
| PRIMECAP MANAGEMENT CO/CA/ | 02/10/2025 | 280,800 | $2.98 M | 0.00% | 0.47% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 273,761 | $2.91 M | -51.85% | 0.45% |
| HANDELSBANKEN FONDER AB | 02/03/2025 | 200,000 | $2.12 M | -13.04% | 0.33% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 189,060 | $2.01 M | 14.24% | 0.31% |
| UBS GROUP AG | 02/14/2025 | 188,197 | $2.00 M | 137.50% | 0.31% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 186,087 | $1.98 M | -1.55% | 0.31% |
| AXA S.A. | 02/14/2025 | 179,458 | $1.91 M | -0.16% | 0.30% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 158,428 | $1.68 M | 100.00% | 0.26% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 154,467 | $1.64 M | 100.00% | 0.26% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 145,564 | $1.55 M | 3.46% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 123,203 | $1.31 M | -1.39% | 0.20% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 107,794 | $1.14 M | -32.12% | 0.18% |
| BARCLAYS PLC | 02/13/2025 | 104,314 | $1.11 M | -1.48% | 0.17% |
| CITADEL ADVISORS LLC | 02/14/2025 | 95,866 | $1.02 M | 100.00% | 0.16% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 84,930 | $901,954 | 100.00% | 0.14% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 82,595 | $877,159 | 59.97% | 0.14% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 81,391 | $864,372 | -6.54% | 0.14% |
| CITIGROUP INC | 02/12/2025 | 77,236 | $820,247 | 105.58% | 0.13% |
| SWISS NATIONAL BANK | 02/10/2025 | 76,400 | $811,368 | 0.00% | 0.13% |
| RHUMBLINE ADVISERS | 01/30/2025 | 68,167 | $723,924 | -1.23% | 0.11% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 58,193 | $618,009 | 32.66% | 0.10% |
| PROSIGHT MANAGEMENT, LP | 02/14/2025 | 54,342 | $577,112 | 38.86% | 0.09% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 53,790 | $571,250 | 0.00% | 0.09% |
| MAGNUS FINANCIAL GROUP LLC | 01/17/2025 | 53,536 | $568,552 | 107.83% | 0.09% |
| CERITY PARTNERS LLC | 02/13/2025 | 52,678 | $663,025 | -0.80% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Immunome, Inc. institutional Ownership - FAQ's
During the previous two years, 139 institutional investors and hedge funds held shares of Immunome, Inc.. The most heavily invested institutionals were:
Parallel Advisors, LLC: 0
T. Rowe Price Investment Management, Inc.: 5.5 M
Redmile Group, LLC: 4.83 M
BlackRock, Inc.: 4.12 M
FMR LLC: 3.92 M
EcoR1 Capital, LLC: 3.88 M
88.55% of Immunome, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 53.69 M shares in the last 24 months. This purchase volume represents approximately $385.51 M in transactions.